GSK
Pharma needs ‘radical change’ says report
April 9, 2014Medical Communications, Sales and Marketing Chris Stirling, GSK, KPMG, digital
The pharma industry needs a complete overhaul of its entire business model with a greater focus on the patient, according …
More manufacturing misery for GSK
April 4, 2014Manufacturing and Production, Sales and Marketing GSK, Ireland, Paxil, cork, manufacturing
GlaxoSmithKline’s manufacturing woes are getting worse after the firm was hit with a second FDA warning in as many days. …
FDA slams GSK for manufacturing oversights
April 3, 2014Manufacturing and Production FDA, GMP, GSK, Ireland, cork, mage, manufacturing
The FDA has warned GlaxoSmithKline that the US importation of products from the firm’s facility in Cork, Ireland could be …
GSK China rep speaks out over ‘bribery culture’
April 2, 2014Medical Communications, Sales and Marketing China, GSK, Shanghai, Witty, bribery, sales
A former sales representative for GlaxoSmithKline has spoken of the firm’s alleged tactics in bribing poorly paid doctors in China …
‘More patients want Votrient’
April 2, 2014Research and Development, Sales and Marketing Cancer, GSK, Pfizer, Sutent, Votrient
GlaxoSmithKline is looking at patient satisfaction as a potential marketing tool for its kidney cancer drug Votrient, setting up a …
Lung cancer vaccine dropped
April 2, 2014Research and Development, Sales and Marketing GSK, MAGE-A3, NSCLC, Vaccine, lung cancer, magrit
GlaxoSmithKline took a hit today after its lung cancer vaccine MAGE-A3 failed to benefit patients. The London-based firm has now …
Votrient’s extended licence application ditched
April 1, 2014Sales and Marketing EMA, Europe, GSK, ovarian, votrient kidney cancer
GlaxoSmithKline admits it is ‘disappointed’ after abandoning its attempt to extend kidney cancer drug Votrient’s licence to take in ovarian …
GSK invests £130m in Africa
April 1, 2014Manufacturing and Production, Research and Development, Sales and Marketing Africa, GSK, Nigeria, kenya, rwanda, sub-saharan
GlaxoSmithKline is to invest £130 million in sub-Saharan Africa over the next five years – money which the company says …
GSK takes possession of Indonesian consumer healthcare unit
March 31, 2014Manufacturing and Production, Sales and Marketing GSK, Indonesia, bognor, emerging markets, insto, sarasvati
GlaxoSmithKline has acquired full ownership of its Indonesian consumer healthcare business in a transaction which also sees the company divesting …
Europe grants Eperzan licence
March 27, 2014Sales and Marketing Bydureon, GSK, diabetes, eperzan, lilly
The European Commission has granted marketing authorisation to GlaxoSmithKline’s new diabetes treatment Eperzan – setting the manufacturer on a collision …
Alli bottles tampered with in US, drug recalled
March 27, 2014Manufacturing and Production, Sales and Marketing Alli, FDA, GSK, Roche, Xenical, obesity, weight loss
GlaxoSmithKline has admitted that some bottles of its weight-loss drug Alli bought in the US have been tampered with. US …
GSK and partners set up big data project
March 27, 2014Medical Communications, Research and Development, Sales and Marketing Big Data, European Bioinformatics Institute, GSK, Wellcome Trust Sanger Institute, cttv
GlaxoSmithKline, the European Bioinformatics Institute and the Wellcome Trust Sanger Institute have come together to launch an open access research …
GSK cancer vaccine fails again
March 20, 2014Sales and Marketing Cancer, GSK, MAGE-A3 cancer immunotherapeutic, NSCLC, lung cancer, melanoma
GlaxoSmithKline’s MAGE-A3 cancer immunotherapeutic has delivered another late-stage blow to the firm but it still vows to continue trials. The …
GSK increases India stake
March 11, 2014Manufacturing and Production, Sales and Marketing FDA, GSK, India, Nashik, OTC, Thane, bangalore
GlaxoSmithKline has taken a further step into the Indian pharma market by increasing its stake in its subsidiary company there, …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
